EFFECTIVENESS OF ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOLS IN BREAST CANCER SURGERY AT A TERTIARY CARE HOSPITAL IN KHYBER PAKHTUNKHWA PAKISTAN
DOI:
https://doi.org/10.55519/JAMC-S4-13153Abstract
Background: Breast cancer treatment outcomes have markedly improved over the years with advancements in knowledge and treatment options. Enhanced recovery after surgery (ERAS) has been introduced recently to enhance post-operative patient wellbeing, attain enhanced recovery for patients who undergo major surgery, and therefore facilitate a drop in hospital length of stay (LOS). These may also furnish an additional advantage of decreasing health care costs while refining the standard of care and patient contentedness. Methods: A quasi experimental study was conducted in the breast unit of Khyber Teaching Hospital, with a sample size of 30 in each group with a 95% confidence interval and a 5% margin of error. A consecutive non-probability sampling technique was used and the study was conducted in 6 months after taking ethical approval from the ethical review committee MTI, KTH. Comparison was done between both groups for effectiveness, noted with regard to hospital stay, post-op pain and complication rate. Results: The mean age of the patients in the ERAS group was 56.30±5.615 years while the mean age in the non-ERAS group was 56.07±6.11 years. The wound infection was observed in 11 patients with ERAS (36.7%) as compared to 12 (40.0%) without ERAS. Hospital stay was longer in non-ERAS as compared to ERAS with a mean difference of 1.833 and p-value of 0.000 while the post-op VAS mean difference was 1.267 with p value of 0.001. Conclusion: Evidence supports the effectiveness, affordability, and safety of ERAS protocols as it leads to a noticeable decrease in hospitalization duration, resulting in reduced resource consumption and financial burdens. Nonetheless, achieving the mentioned benefits may necessitate strict adherence to the protocol, which could be challenging due to professional, institutional, and personal resistance.
References
1. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell 2000;100(1):57–70.
2. Sung H, Ferlay J, Siegel R.L, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin 2021;71(3):209–49.
3. Duggan C, Dvaladze A, Rositch AF, Ginsburg O, Yip C, Horton S, et al. The Breast Health Global Initiative 2018 Global Summit on Improving Breast Healthcare Through Resource-Stratified Phased Implementation: Methods and overview. Cancer 2020;126(Suppl 10):2339–52.
4. WHO. Global Health Estimates 2016: Disease Burden by Cause, Age, Sex, by Country and by Region, 2000–2016. World Health Organization; Geneva, Switzerland: 2018.
5. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Obser-Vatory: Cancer Today. International Agency for Research on Cancer; Lyon, France: 2020.
6. DeSantis CE, Fedewa SA, Sauer AG, Kramer JL, Smith RA, Jemal A. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. CA A Cancer J Clin 2015;66(1):31–42.
7. Sharma R. Global, regional, national burden of breast cancer in 185 countries: Evidence from GLOBOCAN 2018. Breast Cancer Res Treat 2021;187(2):557–67.
8. Ginsburg O, Bray F, Coleman M, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women’s cancers: A grand challenge in global health. Lancet 2017;389(10071):847–60.
9. Mui J, Cheng E, Salindera S. Enhanced recovery after surgery for oncological breast cancer surgery reduces length of stay in a resource limiting setting. ANZ J Surg 2024;94(6):1096–1101.
10. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: A population-based study. Lancet Oncol 2010;11(2):165–173.
11. Porter P. Westernizing Women’s Risks? Breast Cancer in Lower-Income Countries. N Engl J Med 2008;358(3):213–16.
12. Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, et al. Sex hormones and risk of breast cancer in premenopausal women: A collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol 2013;14(10):1009–19.
13. Folkerd E, Dowsett M. Sex hormones and breast cancer risk and prognosis. Breast 2013;22(Suppl 2):S38–43.
14. Pintault C, Pondovan A, Lebechec A, Jugan AI, Coudrio u C, Berti De M, et al. Implementation of enhanced recover after surgery pathways for patients undergoing mastectomy. J Gynecol Obstet Hum Reprod 2023;52(6):102600.
15. Tan Y, Lu X, Luo J, Huang Z, Deng Q, Shen XF, et al. Enhanced recovery after surgery for breast reconstruction: Pooled meta analysis of 10 observational studies involving 1838 Patients. Front Oncol 2019;9:675.
16. Chiu C, Aleshi P, Esserman L, Inglis-Arkell C, Yap E, Whitlock EL, et al. Improved analgesia and reduced post-operative nausea vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy. BMC Anesthesiol 2018;18(1):41.
17. Rojas K, Fortes T, Flom P, Manasseh D, Andaz C, Borgen PI. Mastectomy is no longer an indication for postoperative opiod prescription at discharge. Am J Surg 2019;218(4):700–5.
18. Dumestre D, Redwood J, Webb C, Temple-Oberle C. enhanced recovery after surgery protocol enables Safe same-day discharge after Alloplastic breast reconstruction. Plast Surg (Oakv) 2017;25(4):249–54.
19. Sulejmani P, Lunt L, Mazur M, Coogan A, Steuer A, O’ Donoghue, et al. Enhanced recovery after surgery and length of stay in Mastectomy patients with reconstruction. J Surg Res 2023;289:158–63.
20. Tippireddy S, Ghatol D. Anesthetic management of Enhanced Recovery after surgery (ERAS). National library of Medicien. StatPearls Publishing 2023.
21. Benz CC. Impact of aging on the biology of breast cancer. Crit Rev Oncol 2008;66(1):65–74.
22. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64(1):9–29.
23. McGuire A, Brown JAL, Malone C, McLaughlin R, Kerin MJ. Effects of Age on the Detection and Management of Breast Cancer. Cancers 2015;7(2):908–29.
24. Stat Bite: Lifetime Probability among Females of Dying of Cancer. J Natl Cancer Inst 2004;96(11):1311–21.
25. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 2001;358(9291):1389–99.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Anum Wahid, Usama Umar, Irum Sabir, Mah Muneer Khan
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
